Sandra (Schrötter) Coveney, PhD, is a Development Scientist at CST with over 10 years of experience in molecular and cellular neurobiology. Previously, Sandra was a Postdoctoral Researcher at Harvard University, where her research focused on using the CRISPR/Cas9 technology to gain a better understanding of the Tuberous Sclerosis Complex (TSC).
